297 related articles for article (PubMed ID: 18789686)
41. Imidazo[2,1-b]thiazole system: a scaffold endowing dihydropyridines with selective cardiodepressant activity.
Budriesi R; Ioan P; Locatelli A; Cosconati S; Leoni A; Ugenti MP; Andreani A; Di Toro R; Bedini A; Spampinato S; Marinelli L; Novellino E; Chiarini A
J Med Chem; 2008 Mar; 51(6):1592-600. PubMed ID: 18303827
[TBL] [Abstract][Full Text] [Related]
42. Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity.
Choi SJ; Park HJ; Lee SK; Kim SW; Han G; Choo HY
Bioorg Med Chem; 2006 Feb; 14(4):1229-35. PubMed ID: 16242334
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and structure-activity relationship of trisubstituted thiazoles as Cdc7 kinase inhibitors.
Reichelt A; Bailis JM; Bartberger MD; Yao G; Shu H; Kaller MR; Allen JG; Weidner MF; Keegan KS; Dao JH
Eur J Med Chem; 2014 Jun; 80():364-82. PubMed ID: 24793884
[TBL] [Abstract][Full Text] [Related]
44. Trisubstituted thiazoles as potent and selective inhibitors of Plasmodium falciparum protein kinase G (PfPKG).
Tsagris DJ; Birchall K; Bouloc N; Large JM; Merritt A; Smiljanic-Hurley E; Wheldon M; Ansell KH; Kettleborough C; Whalley D; Stewart LB; Bowyer PW; Baker DA; Osborne SA
Bioorg Med Chem Lett; 2018 Oct; 28(19):3168-3173. PubMed ID: 30174152
[TBL] [Abstract][Full Text] [Related]
45. Novel tricyclic inhibitors of IkappaB kinase.
Kempson J; Spergel SH; Guo J; Quesnelle C; Gill P; Belanger D; Dyckman AJ; Li T; Watterson SH; Langevine CM; Das J; Moquin RV; Furch JA; Marinier A; Dodier M; Martel A; Nirschl D; Van Kirk K; Burke JR; Pattoli MA; Gillooly K; McIntyre KW; Chen L; Yang Z; Marathe PH; Wang-Iverson D; Dodd JH; McKinnon M; Barrish JC; Pitts WJ
J Med Chem; 2009 Apr; 52(7):1994-2005. PubMed ID: 19267461
[TBL] [Abstract][Full Text] [Related]
46. Traceless solid-phase synthesis of 2-aminothiazoles: receptor tyrosine kinase inhibitors with dual selectivity for Tie-2 and VEGFR-2.
Stieber F; Mazitschek R; Soric N; Giannis A; Waldmann H
Angew Chem Int Ed Engl; 2002 Dec; 41(24):4757-61. PubMed ID: 12481350
[No Abstract] [Full Text] [Related]
47. [Imidazo(2,1-b)thiazole XII derivatives. Synthesis and research of immunoactivity in vitro on human T lymphocyte of 3-aroylmethyl and 2-aroyl-3-methyl(aryl)-5,6-dihydroimidaz o(2,1-b)thiazoles].
Robert JF; Hassanine A; Harraga S; Seilles E
Ann Pharm Fr; 1995; 53(6):261-71. PubMed ID: 8572506
[TBL] [Abstract][Full Text] [Related]
48. [Substituted imidazolidinediones and thiazolidinediones: synthesis, structure and cytotoxic activity].
Barros Costa DL; Chantegrel J; Alves de Lima MC; Cavalcanti Albuquerque JM; Correa Lima RM; Galdino SL; Pitta IR; Luu-Duc C
J Pharm Belg; 1995; 50(1):5-10. PubMed ID: 7602453
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles and 1,3,5-trisubstituted pyrazoles as inhibitors of transforming growth factor beta type 1 receptor (ALK5).
Li X; Wang L; Long L; Xiao J; Hu Y; Li S
Bioorg Med Chem Lett; 2009 Aug; 19(16):4868-72. PubMed ID: 19616940
[TBL] [Abstract][Full Text] [Related]
50. Chemopreventive and antioxidant activity of 6-substituted imidazo[2,1-b]thiazoles.
Andreani A; Leoni A; Locatelli A; Morigi R; Rambaldi M; Cervellati R; Greco E; Kondratyuk TP; Park EJ; Huang K; van Breemen RB; Pezzuto JM
Eur J Med Chem; 2013 Oct; 68():412-21. PubMed ID: 23994869
[TBL] [Abstract][Full Text] [Related]
51. 2-Alkenylthieno[2,3-b]pyridine-5-carbonitriles: Potent and selective inhibitors of PKCtheta.
Nathan Tumey L; Boschelli DH; Lee J; Chaudhary D
Bioorg Med Chem Lett; 2008 Aug; 18(15):4420-3. PubMed ID: 18606543
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and biological evaluation of benzenesulfonamide-substituted 4-(6-alkylpyridin-2-yl)-5-(quinoxalin-6-yl)imidazoles as transforming growth factor-beta type 1 receptor kinase inhibitors.
Kim DK; Jung SH; Lee HS; Dewang PM
Eur J Med Chem; 2009 Feb; 44(2):568-76. PubMed ID: 18467006
[TBL] [Abstract][Full Text] [Related]
53. Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
Angell R; Aston NM; Bamborough P; Buckton JB; Cockerill S; deBoeck SJ; Edwards CD; Holmes DS; Jones KL; Laine DI; Patel S; Smee PA; Smith KJ; Somers DO; Walker AL
Bioorg Med Chem Lett; 2008 Aug; 18(15):4428-32. PubMed ID: 18614366
[TBL] [Abstract][Full Text] [Related]
54. Modifications of the isonipecotic acid fragment of SNS-032: analogs with improved permeability and lower efflux ratio.
Fan J; Fahr B; Stockett D; Chan E; Cheeti S; Serafimova I; Lu Y; Pham P; Walker DH; Hoch U; Choong IC
Bioorg Med Chem Lett; 2008 Dec; 18(23):6236-9. PubMed ID: 18926699
[TBL] [Abstract][Full Text] [Related]
55. Synthesis of imidazo[2,1-b]thiazoles linked to an unprotected carbohydrate moiety.
Barradas JS; Errea MI; D'Accorso NB
Carbohydr Res; 2012 Jul; 355():79-86. PubMed ID: 22595774
[TBL] [Abstract][Full Text] [Related]
56. Design, synthesis, screening, and molecular modeling study of a new series of ROS1 receptor tyrosine kinase inhibitors.
El-Deeb IM; Park BS; Jung SJ; Yoo KH; Oh CH; Cho SJ; Han DK; Lee JY; Lee SH
Bioorg Med Chem Lett; 2009 Oct; 19(19):5622-6. PubMed ID: 19700314
[TBL] [Abstract][Full Text] [Related]
57. Imidazole piperazines: SAR and development of a potent class of cyclin-dependent kinase inhibitors with a novel binding mode.
Finlay MR; Acton DG; Andrews DM; Barker AJ; Dennis M; Fisher E; Graham MA; Green CP; Heaton DW; Karoutchi G; Loddick SA; Morgentin R; Roberts A; Tucker JA; Weir HM
Bioorg Med Chem Lett; 2008 Aug; 18(15):4442-6. PubMed ID: 18617397
[TBL] [Abstract][Full Text] [Related]
58. Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritis.
Dyckman AJ; Langevine CM; Quesnelle C; Kempson J; Guo J; Gill P; Spergel SH; Watterson SH; Li T; Nirschl DS; Gillooly KM; Pattoli MA; McIntyre KW; Chen L; McKinnon M; Dodd JH; Barrish JC; Burke JR; Pitts WJ
Bioorg Med Chem Lett; 2011 Jan; 21(1):383-6. PubMed ID: 21087862
[TBL] [Abstract][Full Text] [Related]
59. Groebke multicomponent reaction and subsequent nucleophilic aromatic substitution for a convenient synthesis of 3,8-diaminoimidazo[1,2-a]pyrazines as potential kinase inhibitors.
Guasconi M; Lu X; Massarotti A; Caldarelli A; Ciraolo E; Tron GC; Hirsch E; Sorba G; Pirali T
Org Biomol Chem; 2011 Jun; 9(11):4144-9. PubMed ID: 21494711
[TBL] [Abstract][Full Text] [Related]
60. Synthesis, biological activity and molecular modeling of 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase.
Yadav V; Chu CK; Rais RH; Al Safarjalani ON; Guarcello V; Naguib FN; el Kouni MH
J Med Chem; 2004 Apr; 47(8):1987-96. PubMed ID: 15055998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
